Prognostic Factors in Metastatic Urothelial Carcinoma Treated Without Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (M-VAC): A Single-Center Retrospective Study.

Saved in:
Bibliographic Details
Title: Prognostic Factors in Metastatic Urothelial Carcinoma Treated Without Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (M-VAC): A Single-Center Retrospective Study.
Authors: Bugday I; Medical Oncology, Erzurum City Hospital, Erzurum, TUR., Inanc M; Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, TUR., Ozkan M; Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, TUR., Bozkurt O; Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, TUR., Cosar R; Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, TUR., Firat ST; Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, TUR., Mutlu E; Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, TUR., Eser M; Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, TUR., Disli AK; Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, TUR., Cengiz M; Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, TUR.
Source: Cureus [Cureus] 2025 Oct 21; Vol. 17 (10), pp. e95066. Date of Electronic Publication: 2025 Oct 21 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-8184
DOI:10.7759/cureus.95066